Zacks.com on MSN1mon
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
Per the data readout, treatment with ARCT-154 showed a stronger and longer-lasting immune response compared with that ...
Zacks.com on MSN15d
Arcturus Gears Up to Report Q3 Earnings: Here's What to Expect
We expect investors to focus on the launch plans of Arcturus Therapeutics Holdings Inc.’s ARCT self-amplifying mRNA (sa-mRNA) ...
Yahoo Finance27d
A slow start for self-amplifying mRNA vaccines
In November 2023, Kostaive (ARCT-154), developed by Arcturus Therapeutics and CSL Behring, was the first samRNA vaccine to gain full marketing approval in Japan to treat Wuhan-Hu-1 strain SARS-Cov-2.
pharmaphorum11mon
CSL, Arcturus get first approval for self-assembling RNA jab
The Ministry of Health, Labour and Welfare (MHLW) gave the green light to CSL and Arcturus’ COVID-19 vaccine ARCT-154 – also known as Lunar-COV19 – which will be commercialised in Japan by ...
The Star3y
Vietnam's ARCT-154 vaccine safe for healthy volunteers according to initial results
HANOI, Oct 1 (Bernama): Initial results of the clinical trials of Vietnam's ARCT-154 show that this mRNA COVID-19 vaccine is safe for healthy volunteers, a researcher said. Phase 2 and 3a of the ...